Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)
Clinical trial NCT04494191 · COMPLETED
Trial details
- NCT number
- NCT04494191
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-12
- Primary completion
- 2018-12-19
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.